An Hong

Transient expression of recombinant sPDGFR alpha-Fc in CHO DG44 cells using 50-mL orbitally shaking disposable bioreactors.

[Experssion of human FGFR2IIIc and its S252W mutant in MDA-MB-231 breast cancer cells with adenovirus vectors].

On-line monitoring of oxygen in Tubespin, a novel, small-scale disposable bioreactor.

Inhibition of α-SMA by the ectodomain of FGFR2c attenuates lung fibrosis.

Cytokines in osteoblast-conditioned medium promote the migration of breast cancer cells.

Constructing regulatory networks to identify biomarkers for insulin resistance.

Homology modeling and molecular docking of human pituitary adenylate cyclase‑activating polypeptide I receptor.

Expression, identification and biological effects of the novel recombination protein, PACAP38-NtA, with high bioactivity.

Engineering of Harobin for enhanced fibrinolytic activity obtained by random and site-directed mutagenesis.

Lnc-mg is a long non-coding RNA that promotes myogenesis.

Urokinase plasminogen activator secreted by cancer-associated fibroblasts induces tumor progression via PI3K/AKT and ERK signaling in esophageal squamous cell carcinoma.

BMP-2 induces EMT and breast cancer stemness through Rb and CD44.

CACNA2D3 Enhances the Chemosensitivity of Esophageal Squamous Cell Carcinoma to Cisplatin via Inducing Ca-Mediated Apoptosis and Suppressing PI3K/Akt Pathways.

miR-671-5p Blocks The Progression Of Human Esophageal Squamous Cell Carcinoma By Suppressing FGFR2.